Equity and Strategic Investors Preferences
This report is a selection of 100+ equity and strategic investors that have interest in investing and supporting life science and healthcare companies that sit within the emerging longevity space, chiefly in the sub sectors of ageing science, the diseases of ageing and agetech.
For the purpose of this report we’ve aggregated and summarised the investment preferences of these firms and highlighted which technology areas are attracting their attention right now.
Their contributions to the ongoing development of this sector cannot be overlooked and if you are not already connected with these firms, they should be on your radar.
These 100+ investors and strategics, make up the first cohort of attendees to the Longevity Leaders Virtual event taking place online, across the 4-7 May.